Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs Midazolam for Recurrence of Suicidality in Adolescents
NCT04592809Phase 3Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Oct 2022
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in Suicidality, sponsored by UT Southwestern Medical Center. Started Oct 2022; status: completed.
02
Drugs
ketamine
03
Conditions
Suicidality
Beyond the preview
Go deeper on NCT04592809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04592809.